SEC Company Response from TELA Bio, (TELA) — Jun 23, 2020

TELA Bio, Inc.
Date: June 23, 2020 · CIK: 0001561921 · Accession: 0001104659-20-076115

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-239386

Date

June 23, 2020

Author

Not clearly detected

Form

CORRESP

Company

TELA Bio, Inc.

Letter

TELA Bio, Inc.

1 Great Valley Parkway, Suite 24

Malvern, Pennsylvania 19355

June 23, 2020

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Manufacturing

100 F Street NE

Washington, D.C. 20549

Attn: Jason L. Drory

Re: TELA Bio, Inc.

Registration Statement on Form S-1

SEC File No. 333-239386

Filed June 23, 2020

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, TELA Bio, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (File No. 333-239386) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:00 PM, eastern time, on June 25, 2020, or as soon thereafter as is practicable.

Please feel free to direct any questions or comments concerning this request to Rachael Bushey, Esq. of Pepper Hamilton LLP at (215) 981-4331.

The Company understands that the staff of the United States Securities and Exchange Commission will consider this request as confirmation by the Company that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.

TELA BIO, Inc.

By: /s/ Antony Koblish

Name: Antony Koblish

Title: President and Chief Executive Officer

Cc: Rachael Bushey, Pepper Hamilton LLP

Show Raw Text

CORRESP
1
filename1.htm

TELA Bio, Inc.

1 Great Valley Parkway, Suite 24

Malvern, Pennsylvania 19355

June 23, 2020

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Manufacturing

100 F Street NE

Washington, D.C. 20549

Attn: Jason L. Drory

    Re:
    TELA Bio, Inc.

    Registration Statement on Form S-1

    SEC File No. 333-239386

    Filed June 23, 2020

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities
Act of 1933, as amended, TELA Bio, Inc. (the “Company”) hereby requests that the effective date of the Company’s
Registration Statement on Form S-1 (File No. 333-239386) (the “Registration Statement”) be accelerated so that the
Company’s Registration Statement will become effective at 4:00 PM, eastern time, on June 25, 2020, or as soon thereafter
as is practicable.

Please feel free to direct any questions or
comments concerning this request to Rachael Bushey, Esq. of Pepper Hamilton LLP at (215) 981-4331.

The Company understands that the staff of
the United States Securities and Exchange Commission will consider this request as confirmation by the Company that it is aware
of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration
Statement.

    TELA BIO, Inc.

    By:
    /s/ Antony Koblish

    Name: Antony Koblish

    Title: President and Chief Executive Officer

Cc: Rachael Bushey, Pepper Hamilton LLP

SecProbe.io